Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

Market Cap	12.38B +18.6%
Revenue (ttm)	1.39B +17.6%
Net Income	588.53M +31.5%
EPS	4.88 +34.8%
Shares Out	120.84M
PE Ratio	20.98
Forward PE	19.69
Dividend	2.30 (2.24%)
Ex-Dividend Date	Jun 5, 2026

Volume	2,103,399
Open	102.02
Previous Close	102.45
Day's Range	98.72 - 102.35
52-Week Range	85.44 - 124.30
Beta	0.19
Analysts	Strong Buy
Price Target	126.21 (+27.11%)
Earnings Date	Aug 26, 2026

About SHA:688016

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft system; Cratos and Castor, a branched aortic stent graft system; Talos, a thoracic stent graft system; and Hercules, a thoracic stent graft system with low ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 822
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688016

Financial Performance

In 2025, SHA:688016's revenue was 1.35 billion, an increase of 11.96% compared to the previous year's 1.21 billion. Earnings were 563.33 million, an increase of 12.19%.